{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:55:10Z","timestamp":1789206910012,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd010120.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000}}],"reference-count":91,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010120.pub3","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T14:53:29Z","timestamp":1639061609000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Non-steroidal anti-inflammatory drugs for acute gout"],"prefix":"10.1002","volume":"2021","author":[{"given":"Caroline MPG","family":"van Durme","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine; Maastricht University Medical Center; Maastricht Netherlands"},{"name":"Department of Rehabilitation Medicine; Centre Hospitalier Chr\u00e9tien; Li\u00e8ge Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir D","family":"Wechalekar","sequence":"additional","affiliation":[{"name":"Rheumatology Unit; Repatriation General Hospital; Daw Park Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert BM","family":"Landew\u00e9","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology; Amsterdam Medical Centre; Amsterdam Netherlands"},{"name":"Department of Rheumatology; Zuyderland Medical Centre; Heerlen Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Pardo Pardo","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, The Ottawa Hospital - General Campus; Ottawa Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Cyril","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University; Monash-Cabrini Department of Musculoskeletal Health and Clinical Epidemiology; Cabrini Health; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e","family":"van der Heijde","sequence":"additional","affiliation":[{"name":"Department of Rheumatology; Leiden University Medical Center; Leiden Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Buchbinder","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University; Monash-Cabrini Department of Musculoskeletal Health and Clinical Epidemiology; Cabrini Health; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"10.1002\/14651858.CD010120.pub3-BIB0001|cit1","first-page":"1422","article-title":"Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study","volume":"15","author":"Altman","year":"1988","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.1780310618","article-title":"Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout","volume":"31","author":"Axelrod","year":"1988","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2125.1985.tb05110.x","article-title":"Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis","volume":"20","author":"Butler","year":"1985","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0149-2918(04)90035-5","article-title":"A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis","volume":"26","year":"2004","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0005|cit5","first-page":"275","article-title":"A comparison of phenylbutazone and flufenamic acid in the treatment of acute gout","volume":"10","author":"Douglas","year":"1970","journal-title":"Annals of Physical Medicine"},{"issue":"4A","key":"10.1002\/14651858.CD010120.pub3-BIB0006|cit6","first-page":"641","article-title":"Meclofenamate sodium in the treatment of acute gout. Results of a double-blind study","volume":"33","author":"Eberl","year":"1983","journal-title":"Arzneimittel-Forschung"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0007|cit7","first-page":"92","article-title":"A comparative, double-blind, parallel study with tenoxicam vs placebo in acute gouty arthritis","volume":"14","author":"Garcia de la Torre","year":"1987","journal-title":"Investigaci\u00f3n M\u00e9dica Internacional"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0140-6736(08)60799-0","article-title":"Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial","volume":"371","author":"Janssens","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD010120.pub3-BIB0009|cit9","first-page":"540","article-title":"The treatment of acute gout arthritis. Double-blind randomized comparative study between nimesulid and indomethacin","volume":"53","author":"Klumb","year":"1996","journal-title":"Revista Brasileira de Medicina"},{"issue":"6","key":"10.1002\/14651858.CD010120.pub3-BIB0010|cit10","first-page":"344","article-title":"A double-blind comparison of etodolac (Lodine) and high doses of naproxen in the treatment of acute gout","volume":"7","author":"Lederman","year":"1990","journal-title":"Advances in Therapy"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3760\/cma.j.issn.0366-6999.20122892","article-title":"Etoricoxib versus indomethacin in the treatment of Chinese patients with acute gouty arthritis: a randomized double-blind trial","volume":"126","author":"Li","year":"2013","journal-title":"Chinese Medical Journal"},{"issue":"3A","key":"10.1002\/14651858.CD010120.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9343(86)90131-2","article-title":"Flurbiprofen in the treatment of acute gout. A comparison with indomethacin","volume":"80","author":"Lomen","year":"1986","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1185\/03007999109111513","article-title":"Effectiveness of etodolac ('Lodine') compared with naproxen in patients with acute gout","volume":"12","author":"Maccagno","year":"1991","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.annemergmed.2006.11.014","article-title":"Comparison of oral prednisolone\/paracetamol and oral indomethacin\/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial","volume":"49","author":"Man","year":"2007","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/M14-2070","article-title":"Oral prednisolone in the treatment of acute gout. A pragmatic, multicenter, double-blind, randomized trial","volume":"164","author":"Rainer","year":"2016","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/annrheumdis-2019-216154","article-title":"Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care","volume":"79","author":"Roddy","year":"2020","journal-title":"Annals of Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/art.20007","article-title":"Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomised controlled trial","volume":"50","author":"Rubin","year":"2004","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bmj.324.7352.1488","article-title":"Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis","volume":"324","author":"Boice","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3899\/jrheum.110916","article-title":"Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: a randomized controlled trial","volume":"39","author":"Schumacher","year":"2012","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0196-0644(95)70037-4","article-title":"Randomized double-blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis","volume":"26","author":"Shrestha","year":"1995","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0021|cit21","first-page":"535","article-title":"Double-blind trial: ketoprofen versus phenylbutazone in acute gouty arthritis (author's translation)","volume":"88","author":"Siegmeth","year":"1976","journal-title":"Wiener Klinische Wochenschrift"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.32.4.351","article-title":"Comparison of indomethacin and phenylbutazone in acute gout","volume":"32","author":"Smyth","year":"1973","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/ard.36.1.80","article-title":"Multicentre trial of naproxen and phenylbutazone in acute gout","volume":"36","author":"Sturge","year":"1977","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/ar4159","article-title":"Rilonacept in the treatment of acute gouty arthritis: a randomised, controlled clinical trial using indomethacin as the active comparator","volume":"15","author":"Terkeltaub","year":"2013","journal-title":"Arthritis Research & Therapy"},{"issue":"7","key":"10.1002\/14651858.CD010120.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/kem090","article-title":"Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout","volume":"46","author":"Willburger","year":"2007","journal-title":"Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.12659\/MSM.895749","article-title":"Comparison of prednisolone, etoricoxib, and indomethacin treatment of acute gouty arthritis: an open-label, randomized, controlled trial","volume":"22","author":"Xu","year":"2016","journal-title":"Medical Science Monitor"},{"issue":"5","key":"10.1002\/14651858.CD010120.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/ijcp.12359","article-title":"Comparison of intramuscular compound betamethasone and oral diclofenac sodium in the treatment of acute attacks of gout","volume":"68","author":"Zhang","year":"2014","journal-title":"International Journal of Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD010120.pub3-BIB0028|cit28","first-page":"30","article-title":"Comparative observation of therapeutic effects of acupuncture combined with infrared irradiation and western medicine on acute gouty arthritis","volume":"22","author":"Zhou","year":"2012","journal-title":"World Journal of Acupuncture"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0029|cit29","first-page":"111","article-title":"Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis","volume":"20","author":"Alloway","year":"1993","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2125.1988.tb03412.x","article-title":"Comparison of the natural history of untreated acute gouty arthritis vs acute gouty arthritis treated with non-steroidal-anti-inflammatory drugs","volume":"26","author":"Arnold","year":"1988","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"45","key":"10.1002\/14651858.CD010120.pub3-BIB0031|cit31","first-page":"1696","article-title":"The acute gout attack","volume":"30","author":"Bach","year":"1979","journal-title":"Medizinische Welt"},{"issue":"4","key":"10.1002\/14651858.CD010120.pub3-BIB0032|cit32","first-page":"156","article-title":"Treatment of acute uric arthritis using perclusone","volume":"20","author":"Cunovic","year":"1973","journal-title":"Reumatizam"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/03009747309097100","article-title":"Treatment of acute attacks of gout with naproxen-C 1674","volume":"2","author":"Cuq","year":"1973","journal-title":"Scandinavian Journal of Rheumatology Supplement"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0034|cit34","first-page":"315","article-title":"Gouty arthritis: prednisolone is as effective as naproxen","volume":"32","author":"Ecker-Schlipf","year":"2009","journal-title":"Medizinische Monatsschrift f\u00fcr Pharmazeuter"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0035|cit35","first-page":"B393","article-title":"Use of oral prednisolone or naproxen for the treatment of acute gout arthritis: a double blind, randomised equivalent trial","volume":"153","author":"Janssens","year":"2009","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"issue":"5","key":"10.1002\/14651858.CD010120.pub3-BIB0036|cit36","first-page":"35","article-title":"Comparison of the time to analgetic and anti-inflammatory effect in the treatment of gouty arthritis with nimesulide and sodium diclofenac","volume":"79","author":"Kudaeva","year":"2007","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1185\/030079907X210750","article-title":"Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout","volume":"23","author":"Navarra","year":"2007","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0038|cit38","unstructured":"Wortmann R Apremilast therapy for acute gouty arthritis ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1185\/03007998009109465","article-title":"Double-blind trial of feprazone and phenylbutazone in acute gout","volume":"6","author":"Reardon","year":"1980","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/03009747809095668","article-title":"Treatment of acute gouty arthritis with proquazone and indomethacin. A comparative, double-blind trial","volume":"21","author":"Ruotsi","year":"1978","journal-title":"Scandinavian Journal of Rheumatology Supplement"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1024\/1661-8157\/a002360","article-title":"Oral steroids are effective in the treatment of acute gout attacks","volume":"15","author":"Steurer","year":"2016","journal-title":"Praxis"},{"issue":"3","key":"10.1002\/14651858.CD010120.pub3-BIB0042|cit42","first-page":"111","article-title":"Piroxicam in treatment of acute gout high dose versus low dose","volume":"68","author":"Tumrasvin","year":"1985","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"2","key":"10.1002\/14651858.CD010120.pub3-BIB0043|cit43","first-page":"133","article-title":"Use of tenoxicam in patients with acute gouty arthritis","volume":"9","author":"Valdes","year":"1987","journal-title":"European Journal of Rheumatology & Inflammation"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/art.1780220420","article-title":"Double-blind study of fenoprofen versus phenylbutazone in acute gouty arthritis","volume":"22","author":"Weiner","year":"1979","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0045|cit45","first-page":"248","article-title":"Corticosteroid therapy for the treatment of acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs","volume":"63","author":"Werlen","year":"1996","journal-title":"Revue du Rhumatisme (English ed.)"},{"issue":"4","key":"10.1002\/14651858.CD010120.pub3-BIB0046|cit46","first-page":"6193","article-title":"Peptic ulcer hemorrhage combined with acute gout: analyses of treatment in 136 cases","volume":"8","author":"Xu","year":"2015","journal-title":"International Journal of Clinical and Experimental Medicine"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2165\/00003495-198800351-00016","article-title":"Clinical experiences with the intramuscular injection of tiaprofenic acid in rheumatic diseases, with particular emphasis on time of onset and duration of the analgesic effect","volume":"35 Suppl 1","author":"Katona","year":"1988","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0048|cit48","first-page":"683","article-title":"Clinical observation on electroacupuncture combined with medicine for treatment of acute gouty arthritis","volume":"25","author":"Yin","year":"2005","journal-title":"Chinese Acupuncture & Moxibustion"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0049|cit49","unstructured":"Therapeutic effect and mechanism of ozonated autohaemotherapy for patients with gout"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0050|cit50","unstructured":"American College of Rheumatology 1977 criteria for the classification of acute arthritis of primary gout www.rheumatology.org\/practice\/clinical\/classification\/gout.asp"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2125.1987.tb03132.x","article-title":"Observations on spontaneous improvement in patients with podagra: implications for the therapeutic trials of non-steroidal anti-inflammatory drugs","volume":"24","author":"Bellamy","year":"1987","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1186\/ar1794","article-title":"Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance","volume":"7 Suppl 4","author":"Borer","year":"2005","journal-title":"Arthritis Research & Therapy"},{"issue":"11","key":"10.1002\/14651858.CD010120.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/annrheumdis-2019-215933","article-title":"Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout","volume":"78","author":"Bursill","year":"2019","journal-title":"Annals of Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0054|cit54","unstructured":"Visual Rx [Computer program]. Version 3 Dr. Christopher Cates' EBM website. 2008. http:\/\/www.nntoline.net"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0055|cit55","volume-title":"Statistical Power Analysis for the Behavorial Sciences","author":"Cohen","year":"1988"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD010120.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jama.292.11.1363","article-title":"Clinical trial registration: a statement from the International Committee of Medical Journal Editors","volume":"292","author":"DeAngelis","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0058|cit58","doi-asserted-by":"crossref","unstructured":"Deeks JJ Higgins JT Altman DG Chapter 10. Analysing data and undertaking meta-analyses. In: Higgins JT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020), Cochrane Available from training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch10"},{"issue":"2","key":"10.1002\/14651858.CD010120.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archinte.162.3.265","article-title":"Association of non-steroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study","volume":"162","author":"Feenstra","year":"2002","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010120.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.41247","article-title":"2020 American College of Rheumatology Guideline for the Management of Gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis and Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD010120.pub3-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003831","article-title":"Celecoxib for rheumatoid arthritis","author":"Garner","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD010120.pub3-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003685.pub2","article-title":"Rofecoxib for rheumatoid arthritis","author":"Garner","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0064|cit64","unstructured":"GRADEpro GDT [Computer program]. Version accessed 8 September 2020 Hamilton (ON): McMaster University (developed by Evidence Prime) 2015"},{"issue":"10","key":"10.1002\/14651858.CD010120.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3899\/jrheum.090371","article-title":"Progress in measurement instruments for acute and chronic gout studies","volume":"36","author":"Grainger","year":"2009","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0066|cit66","unstructured":"Higgins JT Altman DG Chapter 8. Assessing risk of bias in included studies. In: Higgins JT, Churchill R, Chandler J, Cumpston MS (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0067|cit67","unstructured":"Higgins JT Eldridge S Chapter 23. Including variants on randomized trials Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Available from training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD010120.pub3-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005521.pub2","article-title":"Systemic corticosteroids for acute gout","author":"Janssens","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD010120.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","article-title":"British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout","volume":"46","author":"Jordan","year":"2007","journal-title":"Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis?","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD010120.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis in acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care & Research"},{"issue":"12","key":"10.1002\/14651858.CD010120.pub3-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub2","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010120.pub3-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008952.pub2","article-title":"Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity","author":"Marks","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010120.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0075|cit75","doi-asserted-by":"crossref","unstructured":"Page MJ Higgins JT Sterne JAC Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020), Cochrane Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch13"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1182\/blood.V91.5.1769","article-title":"Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes","volume":"91","author":"Pouliot","year":"1998","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD010120.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/M16-0570","article-title":"Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0078|cit78","unstructured":"Review Manager (RevMan) [Computer program]. Version 5.4 The Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/rheumatology\/kem150","article-title":"Is gout associated with reduced quality of life? A case-control study","volume":"46","author":"Rhody","year":"2007","journal-title":"Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Annals of Rheumatic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD010120.pub3-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000396.pub3","article-title":"Non-steroidal anti-inflammatory drugs for low back pain","author":"Roelofs","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010120.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3899\/jrheum.090370","article-title":"Outcome domains for studies of acute and chronic gout","volume":"36","author":"Schumacher","year":"2009","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0084|cit84","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ Higgins JT Vist GE Glasziou P Akl EA Skoetz N Chapter 14. Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020), Cochrane. Available from training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch14"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0085|cit85","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JT Santesso N Deeks JJ Glasziou P Chapter 15. Interpreting results and drawing conclusions Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated September 2020), Cochrane. Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch15"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2007.081604","article-title":"Gout is associated with more comorbidities, poorer health-related quality of life and higher health-care utilization in US veterans","volume":"67","author":"Singh","year":"2006","journal-title":"Annals of Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010120.pub3-BIB0087|cit87","volume-title":"Criteria of Diagnosis and Therapeutic Effect of Diseases and Syndromes in Traditional Chinese Medicine","year":"1994"},{"issue":"4","key":"10.1002\/14651858.CD010120.pub3-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003789.pub2","article-title":"Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis","author":"Wienecke","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010120.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/acr.24402","article-title":"Efficacy and safety of pharmacologic interventions in patients experiencing a gout flare: a systematic review and network meta-analysis","volume":"73","author":"Zeng","year":"2021","journal-title":"Arthritis Care and Research"},{"issue":"10","key":"10.1002\/14651858.CD010120.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Annals of Rheumatic Diseases"},{"issue":"9","key":"10.1002\/14651858.CD010120.pub3-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010120.pub2","article-title":"Non-steroidal anti-inflammatory drugs for acute gout","author":"Durme","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T03:22:53Z","timestamp":1726284173000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010120.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Musculoskeletal Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":91,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010120.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,9]]}}}